Home > Quotes > DRTX > Company News
DRTX

Durata Therapeutics, Inc. News Headlines

$7.08
*  
0.01
  negative  
0.14%
Get DRTX Alerts
*Delayed - data as of Jun. 18, 2013 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Durata Therapeutics Q1 13 Earnings Conference Call At 8:30 AM ET
5/9/2013 7:30:00 AM - RTT News

U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
4/12/2013 8:56:00 AM - Dow Jones Business News

Durata Therapeutics Prices Underwritten Public Offering At $7.00/shr
4/12/2013 7:41:00 AM - RTT News

3 Speculative Healthcare Companies With High Levels Of Insider Ownership - Part III
3/26/2013 11:36:00 AM - Seeking Alpha

Trius: Topline Data From Second Phase III Trial Of Tedizolid Is Imminent
3/18/2013 8:54:00 AM - Seeking Alpha

Stephen Brozak: Changing The Way Money Is Made And Diseases Are Cured
1/25/2013 2:11:00 PM - Seeking Alpha

Durata Therapeutics: Low Floater With Near-Term Phase III Catalyst
1/9/2013 6:15:00 PM - Seeking Alpha

2 Biotech Firms To Consider In The Wake Of Positive Clinical Data
12/11/2012 3:50:00 PM - Seeking Alpha

5 Low-Debt Biotech Stocks Forecasted For Growth
9/22/2012 9:09:00 AM - Seeking Alpha

An Investment Update On Trius Therapeutics' Tedizolid
8/22/2012 10:34:14 AM - SeekingAlpha

IPO market heats up with four mid-summer deals, 11 on the calendar
7/20/2012 5:56:11 PM - Renaissance Capital

Durata Therapeutics prices IPO at $9, below the range
7/18/2012 7:32:41 PM - Renaissance Capital

5 US IPOs planned for the week of Jul 16
7/16/2012 8:00:07 AM - Renaissance Capital

Durata Therapeutics sets terms for $75 million US IPO
7/9/2012 5:14:07 PM - Renaissance Capital